ERA Fundamental Analysis - ERAMET

Name: ERAMET (ERA) Stock
Brand: ERAMET
Rating: 3.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ERA. ERA was compared to 39 industry peers in the Metals & Mining industry. Both the profitability and financial health of ERA have multiple concerns. ERA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ERA has reported negative net income.

In the past year ERA has reported a negative cash flow from operations.

ERA had positive earnings in 4 of the past 5 years.

Of the past 5 years ERA 4 years had a positive operating cash flow.

1.2 Ratios

ERA has a Return On Assets of -1.58%. This is in the lower half of the industry: ERA underperforms 64.86% of its industry peers.

The Return On Equity of ERA (-9.29%) is worse than 67.57% of its industry peers.

ERA has a Return On Invested Capital of 0.84%. This is in the lower half of the industry: ERA underperforms 67.57% of its industry peers.

The Average Return On Invested Capital over the past 3 years for ERA is in line with the industry average of 7.93%.

The last Return On Invested Capital (0.84%) for ERA is well below the 3 year average (7.61%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	-1.58%
ROE	-9.29%
ROIC	0.84%

ROA(3y)4.1%

ROA(5y)1.33%

ROE(3y)16.44%

ROE(5y)-1.91%

ROIC(3y)7.61%

ROIC(5y)8.07%

1.3 Margins

In the last couple of years the Profit Margin of ERA has declined.

ERA's Operating Margin of 1.91% is on the low side compared to the rest of the industry. ERA is outperformed by 70.27% of its industry peers.

In the last couple of years the Operating Margin of ERA has declined.

With an excellent Gross Margin value of 68.15%, ERA belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.

ERA's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	1.91%
PM (TTM)	N/A
GM	68.15%

OM growth 3Y-46.5%

OM growth 5Y-18.83%

PM growth 3Y-61.12%

PM growth 5YN/A

GM growth 3Y-3.21%

GM growth 5Y23.96%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ERA is destroying value.

Compared to 1 year ago, ERA has more shares outstanding

Compared to 5 years ago, ERA has more shares outstanding

The debt/assets ratio for ERA has been reduced compared to a year ago.

2.2 Solvency

ERA has an Altman-Z score of 1.09. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.09, ERA is not doing good in the industry: 72.97% of the companies in the same industry are doing better.

ERA has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.

ERA has a worse Debt to Equity ratio (2.03) than 86.49% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.03
Debt/FCF	N/A
Altman-Z	1.09

ROIC/WACC0.09

WACC9.26%

2.3 Liquidity

ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.

ERA has a Current ratio of 1.54. This is in the lower half of the industry: ERA underperforms 64.86% of its industry peers.

A Quick Ratio of 1.06 indicates that ERA should not have too much problems paying its short term obligations.

ERA has a Quick ratio of 1.06. This is comparable to the rest of the industry: ERA outperforms 45.95% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.54
Quick Ratio	1.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ERA have decreased strongly by -221.18% in the last year.

ERA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.00% yearly.

ERA shows a decrease in Revenue. In the last year, the revenue decreased by -6.91%.

Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.

EPS 1Y (TTM)-221.18%

EPS 3Y-64%

EPS 5YN/A

EPS Q2Q%-268.75%

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-7.18%

Revenue growth 5Y-4.39%

Sales Q2Q%-3.31%

3.2 Future

ERA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -58.83% yearly.

The Revenue is expected to grow by 8.00% on average over the next years. This is quite good.

EPS Next Y-302.65%

EPS Next 2Y-68.14%

EPS Next 3Y-58.83%

EPS Next 5YN/A

Revenue Next Year4.89%

Revenue Next 2Y7.19%

Revenue Next 3Y8%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.

Also next year ERA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ERA is valued a bit more expensive than the industry average as 67.57% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.98

4.3 Compensation for Growth

ERA's earnings are expected to decrease with -58.83% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-68.14%

EPS Next 3Y-58.83%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.48%, ERA has a reasonable but not impressive dividend return.

Compared to an average industry Dividend Yield of 2.56, ERA pays a bit more dividend than its industry peers.

Compared to an average S&P500 Dividend Yield of 2.44, ERA has a dividend comparable with the average S&P500 company.

		Industry Rank	Sector Rank
Dividend Yield	2.48%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years1

5.3 Sustainability

The earnings of ERA are negative and hence is the payout ratio. ERA will probably not be able to sustain this dividend level.

DP-44.33%

EPS Next 2Y-68.14%

EPS Next 3Y-58.83%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ERAMET

EPA:ERA (11/14/2025, 7:00:00 PM)

54.55

+0.05 (+0.09%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)10-30 2025-10-30

Earnings (Next)02-17 2026-02-17/amc

Inst Owners12.66%

Inst Owner ChangeN/A

Ins Owners0.17%

Ins Owner ChangeN/A

Market Cap1.57B

Revenue(TTM)2.88B

Net Income(TTM)-97.00M

Analysts52.73

Price Target52.22 (-4.27%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.48%

Yearly Dividend1.51

Dividend Growth(5Y)N/A

DP-44.33%

Div Incr Years0

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-10.18%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-10.21%

EPS NY rev (3m)-579.77%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-1.13%

Revenue NY rev (3m)-1.92%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.54
P/FCF	N/A
P/OCF	N/A
P/B	1.5
P/tB	2.91
EV/EBITDA	14.98

EPS(TTM)-3.44

EYN/A

EPS(NY)-3.47

Fwd EYN/A

FCF(TTM)-25.76

FCFYN/A

OCF(TTM)-4.59

OCFYN/A

SpS100.31

BVpS36.3

TBVpS18.78

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.58%
ROE	-9.29%
ROCE	1.16%
ROIC	0.84%
ROICexc	0.99%
ROICexgc	1.13%
OM	1.91%
PM (TTM)	N/A
GM	68.15%
FCFM	N/A

ROA(3y)4.1%

ROA(5y)1.33%

ROE(3y)16.44%

ROE(5y)-1.91%

ROIC(3y)7.61%

ROIC(5y)8.07%

ROICexc(3y)11.46%

ROICexc(5y)11.88%

ROICexgc(3y)13.48%

ROICexgc(5y)14.02%

ROCE(3y)10.76%

ROCE(5y)11.32%

ROICexgc growth 3Y-56.22%

ROICexgc growth 5Y-25.38%

ROICexc growth 3Y-55.33%

ROICexc growth 5Y-24.94%

OM growth 3Y-46.5%

OM growth 5Y-18.83%

PM growth 3Y-61.12%

PM growth 5YN/A

GM growth 3Y-3.21%

GM growth 5Y23.96%

F-Score2

Asset Turnover0.47

Health

		Industry Rank	Sector Rank
Debt/Equity	2.03
Debt/FCF	N/A
Debt/EBITDA	10.29
Cap/Depr	403.31%
Cap/Sales	21.11%
Interest Coverage	0.34
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.54
Quick Ratio	1.06
Altman-Z	1.09

F-Score2

WACC9.26%

ROIC/WACC0.09

Cap/Depr(3y)260.42%

Cap/Depr(5y)209.27%

Cap/Sales(3y)18.57%

Cap/Sales(5y)15.29%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-221.18%

EPS 3Y-64%

EPS 5YN/A

EPS Q2Q%-268.75%

EPS Next Y-302.65%

EPS Next 2Y-68.14%

EPS Next 3Y-58.83%

EPS Next 5YN/A

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-7.18%

Revenue growth 5Y-4.39%

Sales Q2Q%-3.31%

Revenue Next Year4.89%

Revenue Next 2Y7.19%

Revenue Next 3Y8%

Revenue Next 5YN/A

EBIT growth 1Y-51.75%

EBIT growth 3Y-50.34%

EBIT growth 5Y-22.39%

EBIT Next Year19.46%

EBIT Next 3Y25.5%

EBIT Next 5YN/A

FCF growth 1Y-850%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-121.46%

OCF growth 3YN/A

OCF growth 5YN/A

ERAMET / ERA.PA FAQ

What is the fundamental rating for ERA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ERA.PA.

What is the valuation status for ERA stock?

ChartMill assigns a valuation rating of 0 / 10 to ERAMET (ERA.PA). This can be considered as Overvalued.

What is the profitability of ERA stock?

ERAMET (ERA.PA) has a profitability rating of 3 / 10.

Can you provide the dividend sustainability for ERA stock?

The dividend rating of ERAMET (ERA.PA) is 2 / 10 and the dividend payout ratio is -44.33%.

ERAMET (ERA.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

ERAMET / ERA.PA FAQ

What is the fundamental rating for ERA stock?

What is the valuation status for ERA stock?

What is the profitability of ERA stock?

Can you provide the dividend sustainability for ERA stock?